Trials / Sponsors / Ke Dong, MD
Ke Dong, MD
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | tACS Modulates Speech and Cognitive Impairments in People With PD by Targeting the Medial Frontal Cortex Parkinson Disease | N/A | 2023-08-01 |
| Completed | The Effect of Dual-target tACS Combined With Speech Training on Repetition Disorder After Stroke Aphasia | N/A | 2023-01-01 |